Atara Biotherapeutics, Inc. Quarterly Interest Expense in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q2 2024.
  • Atara Biotherapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $1.26M, a 8.42% decline year-over-year.
  • Atara Biotherapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $4.99M, a 68.8% increase year-over-year.
  • Atara Biotherapeutics, Inc. annual Interest Expense for 2023 was $5.29M, a 1317% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.99M $1.26M -$116K -8.42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $5.1M $1.15M -$183K -13.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.29M $1.18M +$1.06M +905% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $4.23M $1.4M +$1.27M +1034% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $2.95M $1.38M +$1.25M +968% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $1.71M $1.34M +$1.33M +33300% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $373K $117K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $123K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $129K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.